Goodpasture syndrome (anti-GBM disease)

Board exam relevance: in 3 of 105 exam reports · rank 111
Synonyms
anti-GBM disease, Goodpasture disease, anti-glomerular basement membrane disease, pulmonary-renal syndrome
Specialty
Internal medicine · Nephrology
Images
Histology 1 · Gross specimen 1
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (2)
  2. Definition
  3. Occurrence & epidemiology
  4. Aetiopathogenesis
  5. Clinical features
  6. Diagnosis
  7. Keep learning in the app
  8. Further reading (open access)
  9. Cross-references

Images (2)

Goodpasture syndrome (anti-GBM disease) – Immunofluorescence in anti-GBM disease: linear IgG deposition along the glomerular capillary loopsHistology
Immunofluorescence in anti-GBM disease: linear IgG deposition along the glomerular capillary loopsImage: Adel.stoyanova (Wikimedia Commons) · CC BY-SA 4.0 · Source
Goodpasture syndrome (anti-GBM disease) – gross specimen: Gross lung specimen in Goodpasture syndrome: diffuse alveolar hemorrhage with dark red lung tissueGross specimen
Gross lung specimen in Goodpasture syndrome: diffuse alveolar hemorrhage with dark red lung tissueImage: Yale Rosen from USA (Wikimedia Commons) · CC BY-SA 2.0 · Source
1 / 2

Definition

Anti-GBM disease (Goodpasture disease) is an autoimmune small-vessel disease in which circulating antibodies are directed against the glomerular and alveolar basement membrane. Goodpasture syndrome refers to the combination of rapidly progressive glomerulonephritis and pulmonary hemorrhage (diffuse alveolar hemorrhage) in the presence of anti-GBM antibodies; without lung involvement it is called anti-GBM glomerulonephritis.

Occurrence & epidemiology

The disease is rare; men are slightly more often affected. Pulmonary hemorrhage and glomerulonephritis usually occur together; glomerulonephritis alone is present in 10–20% and lung involvement alone in about 10%.

Aetiopathogenesis

The autoantigen is the noncollagenous NC1 domain of the alpha3 chain of type IV collagen, which is particularly abundant in the basement membranes of renal and pulmonary capillaries. In genetically susceptible people (certain HLA-DR alleles), environmental factors expose the alveolar antigens: most often cigarette smoke, less often viral respiratory infections or inhalation of hydrocarbon solvents. The antibodies bind to basement membranes, fix complement and trigger a cell-mediated inflammatory reaction.

Clinical features

The leading symptom is hemoptysis; it may be absent despite alveolar hemorrhage. Other symptoms are cough, dyspnea up to respiratory failure, fatigue, fever, weight loss and hematuria, sometimes gross hematuria. Pulmonary hemorrhage may precede renal involvement by weeks to years. Auscultation ranges from normal to crackles; edema indicates kidney failure, pallor indicates anemia.

Diagnosis

  • Imaging: chest radiograph or CT with bilateral patchy or diffuse airspace opacities, usually without cavitation, nodules or pleural effusions
  • Anti-GBM antibodies in serum (indirect immunofluorescence or ELISA against the NC1 domain of the alpha3 chain); their detection confirms the diagnosis
  • ANCA: additionally positive in about 10–40%, mostly perinuclear pattern (double-positive form)
  • Urine and kidney function: hematuria, proteinuria, red blood cell casts, rising creatinine
  • Kidney biopsy, especially if antibodies are not detected: focal segmental necrotizing glomerulonephritis with crescents and linear IgG deposition along the glomerular capillaries

Keep learning in the app

In the InnereFuchs app you can learn Goodpasture syndrome (anti-GBM disease) with flashcards, exam questions and image tasks (ECG, chest X-ray, ultrasound, lab values) – free, in your browser or as an app.

Open in browser  About InnereFuchs →

Further reading (open access)

  1. MSD Manual Professional: Anti-Glomerular Basement Membrane (Anti-GBM) Disease
  2. MSD Manual Professional: Rapidly Progressive Glomerulonephritis (RPGN)

Cross-references

Note: Learning content for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.